| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $5.96B | +12.3% |
| Cost of Revenue | $1.16B | -6.4% |
| Gross Profit | $4.80B | +18.0% |
| R&D Expense | $716.8M | +16.8% |
| SG&A Expense | $237.8M | +12.5% |
| Operating Income | $1.80B | +45.3% |
| Interest Expense | $20.0M | -4.8% |
| Pre-tax Income | $2.06B | +54.3% |
| Income Tax | $283.9M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.88B | +105.7% |
| Accounts Receivable | $1.46B | +4.4% |
| Inventory | $315.5M | -34.9% |
| Current Assets | $5.97B | +34.8% |
| Total Assets | $9.76B | +34.5% |
| Current Liabilities | $4.06B | +9.2% |
| Long-term Debt | $994.3M | +0.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $2.26B | +16.7% |
| Investing Cash Flow | -$727.4M | -12.0% |
| Financing Cash Flow | -$50.1M | +96.8% |
| +97.4% |
| Net Income | $1.75B | +52.0% |
| EPS (Basic) | $2.28 | +55.1% |
| EPS (Diluted) | $2.26 | +54.8% |
| Total Liabilities |
| $8.27B |
| +7.1% |
| Stockholders' Equity | $1.49B | +422.4% |